Thromboxane release after reperfusion of chronically ischemic limbs in patients.
We hypothesized that chronic ischemia of peripheral vascular disease would lead to increased thromboxane A2 (TxA2) and decreased prostacyclin (PGI2) production and surgical correction of the ischemia would stabilize TxA2 and PGI2 at normal levels. TxA2 and PGI2 concentrations were determined in 22 patients before, during, and after arterial reconstruction for limb salvage and in 10 control subjects. Control samples and preoperative patient samples had no detectable TxA2 or PGI2 (less than 26 pg/ml). Five minutes after reperfusion TxA2 increased (TxA2 = 76.27 +/- 48.9 pg/ml, mean +/- SEM) and persisted at 1 day (TxA2 = 190.1 +/- 80.1 pg/ml), 2 days (TxA2 = 224.7 +/- 131.7 pg/ml), 5 days (TxA2 = 334.8 +/- 272.8 pg/ml), and 7 days postoperatively (TxA2 = 256.6 +/- 149.0 pg/ml). Elevated TxA2 production was not associated with chronic ischemia of peripheral vascular disease. Reperfusion of the severely ischemic limb caused significant TxA2 release.
Kupinski
A M
AM
Department of Surgery, Albany Medical College, NY 12208.
Feustel
P J
PJ
Shah
D M
DM
Karmody
A M
AM
Leather
R P
RP
D000328:Adult; D001157:Arterial Occlusive Diseases / Q000097:blood / Q000601:surgery*; D011464:Epoprostenol / Q000097:blood*; D005260:Female; D006801:Humans; D007511:Ischemia / Q000601:surgery*; D007866:Leg / Q000098:blood supply*; D008297:Male; D013928:Thromboxane A2 / Q000097:blood*; D013997:Time Factors
D013928:Thromboxane A2; D011464:Epoprostenol